Singapore: Phylogica is collaborating with Cubist Pharmaceuticals in order to evaluate several of its antimicrobial Phyl...
Singapore: Benitec Biopharma appointed Mr Kevin Buchi to its board of directors. Mr Buchi served as CEO of Cephalon, thr...
Singapore: Osiris Therapeutics, a Columbia-based company focused on developing and marketing stem cell products to treat...
Singapore: One of the genes which causes a muscle disease so severe that newborn babies rarely survive beyond a few days...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has recieved Therapeutic Good...
Singapore: Former US President Bill Clinton addressed delegates at AIDS 2014, 20th International AIDS Conference, that f...
Singapore:Â Starpharma Holdings and Makhteshim Agan Group announced a collaboration program that will see Starpharma's...
Singapore: Australian regenerative medicine firm, Orthocell, is looking ahead to raise $8 million through an Initial Pub...
Singapore: Professor Justin Cooper-White of the Australian Institute for Bioengineering and Nanotechnology spent a week ...
Singapore: Novogen has agreed to acquire all of the shares of Triaxial Pharmaceuticals for $1.88 million in a combinatio...
Singapore:Â Sunshine Heart, a global medical device company focused on innovative technologies for moderate to severe ...
Singapore: In an ongoing case where Perth-based Ms Saba Button suffered severe disability following a flu vaccine manufa...
Singapore: Global biotechnology industry rebounded strongly in 2013, with public companies achieving double-digit revenu...
Singapore: Australian pharmaceutical company Pharmaxis' research projects conducted in conjunction with the University o...
Singapore: In a bid to provide easier access to primary healthcare services, CQ medicare local has secured funding for t...
Singapore: Clinical Network Services (CNS), an Australia-based CRO offering integrated development services in the plann...
Singapore: Australian CRO, Clinical Network Services (CNS), has acquired the business assets of its erstwhile New Zealan...
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...
Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen B...
Singapore: Australian Therapeutic Goods Administration (TGA) has approved Novartis' Bexsero, a multi-component Meningoco...
Singapore: Australian biotech firm, Themis Bioscience GmbH declared the successful interim results of their prophylactic...
Singapore: Universal Biosensors, developer of cardiac marker biosensor, is one-of-the-seven firms to receive Technology ...
Singapore: Current president of CSL Behring, Mr Paul Perreault, will be the new CEO of the firm after Dr Brian McNamee s...
Singapore: GE Healthcare Life Sciences has chosen Ms Jane Stout (from the US), Ms Anushree Balachandran (from Australia)...
Singapore:Â Patient recruitment in phase II CALM trial has accelerated significantly in the past three months with 25 ...
